There are no links to the official documents for the years 1989 through 1995.
The information below can only be used as help for further research, as
there is not enough information here to rely on for official guidance.
For that you need to obtain a copy of the complete document.
Rev. Rul. 95-26
Short sales of securities by partnerships. Short sales of securities
by partnerships create partnership liabilities for purposes of section 752 of the Code.
Rev. Rul. 95-28
Morality tables; Retirement Protection Act of 1994. Mortality tables
pursuant to section 412(1) of the Code as added by section 751(a) of the Retirement
Protection Act of 1994 are set forth.
The Service requests comments on a proposed revenue ruling relating
to tax consequences of private practice physician recruitment incentives provided by
hospitals described in section 510(c)(3) of the Code.
Determinations have been made to add cyclododecanol,
1,5,9-cyclododecatriene, and adiponitrile to the list of taxable substances in section
4672(a)(3) of the Code.
Petitions to add hexabromocyclododecane and
ethylenebistetrabromophthalimide to the list of taxable substances in section 4672(a)(3)
of the Code have been filed.
The Internal Revenue Service and the Treasury Department are
considering simplifying the classification regulations to allow taxpayers to treat
domestic unincorporated business organizations as partnerships or as associations on an
elective basis. The Service and Treasury also are considering adopting similar rules for
foreign business organizations. Comments are requested regarding this and other possible
approaches to simplifying the regulations.
Publication 557, Tax-Exempt Status for Your Organization (Rev. Jan.
1995), is now available.
You can either: Search all IRS Bulletin Documents issued since January 1996, or Search the entire site. For a more focused search, put your search word(s) in quotes.
You can search either the entire GAO Reports section, or all of UncleFed 's
Tax*Board. For a more focused search, put your search word(s) in quotes.